The resumption of the Johnson & Johnson (J&J) vaccine programme awaits approval of its updated protocol by the SA Health Products Regulatory Authority (Sahpra) and a group of university research ethics committees before the stalled programme can restart.

“Once we have received the formal documentation, we will be able to critically evaluate it and turn it around very quickly,” said Prof Marc Blockman, chair of the human research ethics committee at the University of Cape Town’s faculty of health...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now